The mastopexy market has seen considerable growth due to a variety of factors.
• The mastopexy market has grown strongly in recent years. It is set to rise from $2.36 billion in 2024 to $2.52 billion in 2025, with a CAGR of 6.5%.
This growth is attributed to the increased social acceptance of cosmetic procedures, the rising number of bariatric surgery patients, the adoption of virtual consultations and telemedicine, the growth of specialized cosmetic surgery centers, and patient-centered care models.
The mastopexy market is expected to maintain its strong growth trajectory in upcoming years.
• The mastopexy market is projected to experience significant growth in the coming years, reaching $3.21 billion by 2029 at a CAGR of 6.2%.
Factors driving this growth include improved pre-operative counseling, better post-operative care, a stronger focus on overall health and self-care, advanced anesthesia techniques, an aging population, and higher disposable incomes. Key trends include advancements in implant technology, surgical training, regenerative medicine, scar management, and ongoing research.
The rising female geriatric population is expected to contribute to the growth of the mastopexy market. As women aged 65 and older become a larger demographic, the demand for breast lift surgery increases, driven by factors like increased life expectancy and healthcare improvements. The World Bank Group reported a rise in the percentage of women aged 65 and above in the U.S. from 18.1% in 2021 to 19.1% in 2023, indicating that the aging female population is driving the mastopexy market.
The mastopexy market covered in this report is segmented –
1) By Type: Benelli Lift Or Donut Lift, Crescent Breast Lift, Lollipop Lift, Anchor Breast Lift
2) By Tissue Incision: Skin, Adipose, Glandular
3) By End Use: Hospitals, Specialty Clinics
Subsegments:
1) By Benelli Lift Or Donut Lift: Periareolar Mastopexy, Circumareolar Mastopexy
2) By Crescent Breast Lift: Partial Crescent Lift, Full Crescent Lift
3) By Lollipop Lift: Vertical Mastopexy, Single Vertical Incision Mastopexy
4) By Anchor Breast Lift: Inverted T Mastopexy, Wise Pattern Mastopexy
Key players in the mastopexy market are strategically concentrating on the creation of cutting-edge products such as nipple reconstruction solutions, in an effort to maximize their competitive advantage in the industry. These solutions relate to surgical interventions and implants used for reconstructing the nipple-areola complex for patients who have had mastectomies or breast reconstructive surgeries and seek to reinstate the natural look and balance of their breasts. Innovative materials and precision-based surgical methods are often used to accomplish a realistically textured, prominently projected, and aesthetically aligned integration with the surrounding breast tissue. For example, in March 2024, GC Aesthetics, a medical technology organization based in Ireland, revealed the FixNip NRI, a nipple implant designed to radically change the way breast reconstruction is done for women. The intention behind this implant is to enhance the standard of care in comprehensive breast reconstruction by providing a robust and natural-looking nipple-areola complex(NAC) reconstruction. Crafted from biocompatible, smooth silicone, the FixNip NRI comes equipped with a floral-shaped nitinol frame. Its inventive design permits minimal incisions and ensures the implant regains its native shape once it's inserted and folded.
Major companies operating in the mastopexy market are:
• AbbVie Inc.
• Hologic Inc.
• Spire Healthcare Group plc
• Cynosure Inc.
• Silimed - Industria Ltda Implants
• Establishment Labs Holdings Inc.
• Aurora Clinics
• Mentor Worldwide LLC
• Sientra Inc.
• GC Aesthetics
• Sebbin SAS
• Laboratoires Arion
• Polytech Health & Aesthetics GmbH
• Ideal Implant Incorporated
• Surgiform Technology Ltd
• The Esthetic Clinics
• Olympus Cosmetic Group
• Q Medical Industries
• Guangzhou Wanhe Plastic Materials
• Rau Plastic Surgery
North America was the largest region in the mastopexy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mastopexy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.